US FDA approves Gamida’s blood cancer therapy Stock Market Stocks to buy Stocks to sell admin April 17, 2023 0 105 1 minute read The U.S. Food and Drug Administration has approved Gamida Cell Ltd’s blood cancer therapy, Omisirge, the health regulator said on Monday.